Phosphate enemas in childhood: cause for concern.

PubWeight™: 1.55‹?› | Rank: Top 4%

🔗 View Article (PMC 1669662)

Published in BMJ on May 04, 1991

Authors

M McCabe1, J R Sibert, P A Routledge

Author Affiliations

1: Department of Child Health, University of Wales College of Medicine, Llandough Hospital, South Glamorgan.

Articles by these authors

(truncated to the top 100)

Childhood accidents--an endemic of epidemic proportion. Arch Dis Child (1981) 5.81

Child-resistant packaging and accidental child poisoning. Lancet (1977) 5.63

Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: randomised trial. BMJ (2007) 3.26

How long do we need to observe head injuries in hospital? Arch Dis Child (1984) 3.05

Patient reporting of suspected adverse drug reactions: a review of published literature and international experience. Br J Clin Pharmacol (2007) 2.97

Comprehensive clinical drug information service: first year's experience. Br Med J (1977) 2.77

Epidemiology of Munchausen syndrome by proxy, non-accidental poisoning, and non-accidental suffocation. Arch Dis Child (1996) 2.59

A four week study of accidents to children in South Glamorgan. Public Health (1978) 2.57

Patterns of injuries to children on public playgrounds. Arch Dis Child (1994) 2.53

Drowning and near drowning in children in the United Kingdom: lessons for prevention. BMJ (1992) 2.23

Outcome in children who nearly drown: a British Isles study. BMJ (1991) 2.15

Changing patterns of self-poisoning in a UK health district. QJM (1996) 2.13

Bicycle injuries in children. Br Med J (1977) 2.07

Epilepsy in children and the risk of drowning. Arch Dis Child (1993) 2.04

Factors affecting warfarin requirements. A prospective population study. Eur J Clin Pharmacol (1979) 1.95

Poisoning in children. Br Med J (1973) 1.94

Objective birth data and the prediction of child abuse. Arch Dis Child (1981) 1.91

Flexible induction dose regimen for warfarin and prediction of maintenance dose. Br Med J (Clin Res Ed) (1984) 1.83

Clinical pharmacokinetics of propranolol. Clin Pharmacokinet (1979) 1.81

Screening for Duchenne muscular dystrophy. Arch Dis Child (1989) 1.78

Anticoagulants in venous thromboembolism. BMJ (1988) 1.77

Physiological and behavioural thermoregulation in bigeye tuna (Thunnus obesus). Nature (1992) 1.76

Lidocaine plasma protein binding. Clin Pharmacol Ther (1980) 1.74

Attitudes of mothers to neonatal screening for Duchenne muscular dystrophy. BMJ (1990) 1.72

Does health education prevent childhood accidents? Postgrad Med J (1984) 1.69

Adenosine stimulates respiration in man. Br J Clin Pharmacol (1985) 1.67

Plasma osmolality, sodium, and urea in healthy breast-fed and bottle-fed infants in Newcastle upon Tyne. Arch Dis Child (1975) 1.66

Improvements in child resistant containers. Arch Dis Child (1985) 1.65

Safety of late acetylcysteine treatment in paracetamol poisoning. Hum Exp Toxicol (1990) 1.65

A scoring system for bruise patterns: a tool for identifying abuse. Arch Dis Child (2002) 1.65

Subdural haemorrhages in infants: population based study. BMJ (1998) 1.64

Random and systematic medication errors in routine clinical practice: a multicentre study of infusions, using acetylcysteine as an example. Br J Clin Pharmacol (2001) 1.63

Predicting patients' warfarin requirements. Lancet (1977) 1.61

Farm accidents in children. BMJ (1992) 1.56

The plasma protein binding of basic drugs. Br J Clin Pharmacol (1986) 1.49

Atropine as possible contaminant of comfrey tea. Lancet (1989) 1.43

Child-resistant containers really are effective. Lancet (1979) 1.43

Carrier detection in Duchenne muscular dystrophy. Evidence from a study of obligatory carriers and mothers of isolated cases. Arch Dis Child (1979) 1.43

Community exposures to chemical incidents: development and evaluation of the first environmental public health surveillance system in europe. J Epidemiol Community Health (2000) 1.39

The effect of intravenous aminophylline on essential tremor. Br J Clin Pharmacol (1997) 1.38

Pharmacokinetics and pharmacodynamics of warfarin at steady state. Br J Clin Pharmacol (1979) 1.36

Increased alpha-1-acid glycoprotein and lidocaine disposition in myocardial infarction. Ann Intern Med (1980) 1.35

Social deprivation and the causes of stillbirth and infant mortality. Arch Dis Child (2001) 1.35

Lignocaine disposition in blood in epilepsy. Br J Clin Pharmacol (1981) 1.35

Patterns of scald injuries. Arch Dis Child (1994) 1.33

Sex-related differences in the plasma protein binding of lignocaine and diazepam. Br J Clin Pharmacol (1981) 1.32

Early diagnosis and secondary prevention of Duchenne muscular dystrophy. Arch Dis Child (1989) 1.30

Transient bradycardia and subsequent sinus tachycardia produced by intravenous adenosine in healthy adult subjects. Br J Clin Pharmacol (1986) 1.29

High-performance liquid chromatographic analysis of isoniazid and acetylisoniazid in biological fluids. J Chromatogr (1983) 1.27

Free and total plasma theophylline concentrations in chronic airflow obstruction. Thorax (1984) 1.26

Accidental poisoning in children: can we admit fewer children with safety? Arch Dis Child (1991) 1.25

Duchenne muscular dystrophy in Wales: a 15 year study, 1971 to 1986. J Med Genet (1989) 1.24

Implications of diagnostic delay in Duchenne muscular dystrophy. Br Med J (Clin Res Ed) (1983) 1.23

A simple method for determining acetylator phenotype using isoniazid. Br J Clin Pharmacol (1986) 1.22

The impact of nationally distributed guidelines on the management of paracetamol poisoning in accident and emergency departments. National Poison Information Service. J Accid Emerg Med (1998) 1.22

Recent developments in the management of paracetamol (acetaminophen) poisoning. Drug Saf (1992) 1.21

A method to prevent the loss of isoniazid and acetylisoniazid in human plasma. Br J Clin Pharmacol (1983) 1.20

Determinants of the plasma protein binding of theophylline in health. Br J Clin Pharmacol (1983) 1.19

Diazepam and lidocaine plasma protein binding in renal disease. Clin Pharmacol Ther (1982) 1.19

Congenital adrenal hyperplasia--a clinical and genetic survey. Are we detecting male salt-losers? Arch Dis Child (1980) 1.19

Accidental childhood poisoning with household products. Br Med J (Clin Res Ed) (1984) 1.18

Monitoring effects of oral anticoagulants during treatment with heparin. Br Med J (Clin Res Ed) (1984) 1.18

Intravenous adenosine in the treatment of supraventricular tachycardia: a dose-ranging study and interaction with dipyridamole. Br J Clin Pharmacol (1986) 1.16

Relationship between alpha 1-acid glycoprotein and lidocaine disposition in myocardial infarction. Clin Pharmacol Ther (1981) 1.16

The effects of age and smoking on the plasma protein binding of lignocaine and diazepam. Br J Clin Pharmacol (1985) 1.16

Adenosine-induced respiratory stimulation in man depends on site of infusion. Evidence for an action on the carotid body? Br J Clin Pharmacol (1987) 1.12

Accidental poisoning in children. Br J Hosp Med (1977) 1.11

The epidemiology of sudden infant death syndrome. J Epidemiol Community Health (1982) 1.11

Effects of maternal smoking on fetal growth and nutrition. Arch Dis Child (1981) 1.11

A British family with herediatary pancreatitis. Gut (1975) 1.11

Maternal and fetal nutrition in south India. Br Med J (1978) 1.09

Predicting the dose of warfarin for therapeutic anticoagulation. Thromb Haemost (1982) 1.09

Erythrocyte thiopurine methyl transferase assessment prior to azathioprine use in the UK. QJM (2002) 1.09

Letter: Poisoned children. Br Med J (1974) 1.08

Hereditary pancreatitis in England and Wales. J Med Genet (1978) 1.08

Which radiological investigations should be performed to identify fractures in suspected child abuse? Clin Radiol (2006) 1.07

Should we routinely measure free plasma phenytoin concentration? Br J Clin Pharmacol (1984) 1.07

Hemlock water dropwort poisoning--a review. Clin Toxicol (1978) 1.05

Importance of blood-collection tubes in plasma lidocaine determinations. Clin Chem (1979) 1.05

Childhood drownings in private swimming pools: an avoidable cause of death. Br Med J (Clin Res Ed) (1982) 1.03

Important drug-drug interactions in the elderly. Drugs Aging (1998) 1.02

Accidental ingestion of poisons and child personality. Postgrad Med J (1977) 1.02

Procedures, placement, and risks of further abuse after Munchausen syndrome by proxy, non-accidental poisoning, and non-accidental suffocation. Arch Dis Child (1998) 1.02

Presystemic drug elimination. Annu Rev Pharmacol Toxicol (1979) 1.01

The effect of activated charcoal and hyoscine butylbromide alone and in combination on the absorption of mefenamic acid. Br J Clin Pharmacol (1985) 1.01

Adverse effects of corticosteroids. Adverse Drug React Toxicol Rev (1998) 1.00

A comparison of 3 and 6 weeks' anticoagulation in the treatment of venous thromboembolism. Clin Lab Haematol (1987) 1.00

Accidents and child abuse in bathtub submersions. Arch Dis Child (1994) 1.00

Early development of boys with Duchenne muscular dystrophy. Dev Med Child Neurol (1990) 0.98

Effective reversal of warfarin-induced excessive anticoagulation with low dose vitamin K1. Thromb Haemost (1992) 0.98

Pancreatitis in children. A study in the North of England. Arch Dis Child (1975) 0.97

Labetalol, a cross-over double blind controlled trial. Eur J Clin Pharmacol (1978) 0.96

Control of lidocaine therapy: new perspectives. Ther Drug Monit (1982) 0.96

Determinants of plasma alpha 1-acid glycoprotein (AAG) concentrations in health. Br J Clin Pharmacol (1985) 0.96

Fetal growth and parental consanguinity. Arch Dis Child (1979) 0.95

Hypernatraemic dehydration and necrotizing enterocolitis. Postgrad Med J (1985) 0.95

Paracetamol toxicity: is enzyme induction important? Hum Toxicol (1986) 0.95

On the role of alpha 1-acid glycoprotein in lignocaine accumulation following myocardial infarction. Br J Clin Pharmacol (1982) 0.94

Diazepam and N-desmethyldiazepam redistribution after heparin. Clin Pharmacol Ther (1980) 0.94

Guidelines to control heparin treatment. Br Med J (Clin Res Ed) (1986) 0.94